L. A. Moreno, J. Valtueña, and F. Pérez-lópez, Health Effects Related to Low Vitamin D Concentrations: Beyond Bone Metabolism, Annals of Nutrition and Metabolism, vol.91, issue.1, pp.22-27, 2011.
DOI : 10.1210/jc.2005-1436

J. Smolders, S. M. Moen, and J. Damoiseaux, Huitinga, I.; Holmøy, T. Vitamin D in the healthy and inflamed central nervous system: Access and function, J. Neurol. Sci, pp.311-348, 2011.

C. E. Hayes, F. E. Nashold, C. G. Mayne, J. A. Spanier, and C. D. Nelson, Vitamin D and Multiple Sclerosis, pp.1843-1878, 2011.

B. M. Van-amerongen, C. D. Dijkstra, P. Lips, and C. H. Polman, Multiple sclerosis and vitamin D: an update, European Journal of Clinical Nutrition, vol.22, issue.Suppl 1, pp.1095-1109, 2004.
DOI : 10.1093/oxfordjournals.epirev.a018033

I. A. Van-der-mei, A. L. Ponsonby, T. Dwyer, L. Blizzard, R. Simmons et al., PAST SUN EXPOSURE, SKIN PHENOTYPE AND RISK OF MULTIPLE SCLEROSIS, Epidemiology, vol.14, issue.Supplement, p.316, 2003.
DOI : 10.1097/00001648-200309001-00275

I. A. Van-der-mei, A. L. Ponsonby, T. Dwyer, L. Blizzard, B. V. Taylor et al., Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia, J. Neurol, vol.254, pp.581-590, 2007.

T. J. Kilpatrick, T. Dwyer, A. Coulthard, and C. Chapman, Sun exposure and vitamin D are independent risk factors for CNS demyelination, Neurology, vol.76, pp.540-548, 2011.

K. L. Munger, S. M. Zhang, E. O-'reilly, M. A. Hernán, M. J. Olek et al., Vitamin D intake and incidence of multiple sclerosis, Neurology, vol.62, issue.1, pp.60-65, 2004.
DOI : 10.1212/01.WNL.0000101723.79681.38

K. L. Munger, L. I. Levin, B. W. Hollis, N. S. Howard, and A. Ascherio, Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis, JAMA, vol.296, issue.23, pp.2832-2838, 2006.
DOI : 10.1001/jama.296.23.2832

M. Soilu-hänninen, L. Airas, I. Mononen, A. Heikkilä, M. Viljanen et al., 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis, Multiple Sclerosis Journal, vol.48, issue.3, pp.266-271, 2005.
DOI : 10.1210/jc.2003-030817

M. Soilu-hänninen, M. Laaksonen, I. Laitinen, J. P. Erälinna, and E. M. Lilius, A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.79, issue.2, pp.152-157, 2008.
DOI : 10.1136/jnnp.2006.105320

J. Smolders, P. Menheere, A. Kessels, J. Damoiseaux, and R. Hupperts, Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis, Multiple Sclerosis Journal, vol.86, issue.9, pp.1220-1224, 2008.
DOI : 10.1212/WNL.44.9.1687

J. Kragt, B. Van-amerongen, J. Killestein, C. Dijkstra, B. Uitdehaag et al., Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women, Multiple Sclerosis Journal, vol.80, issue.1, pp.9-15, 2009.
DOI : 10.1073/pnas.0710615105

B. Weinstock-guttman, R. Zivadinov, J. Qu, D. Cookfair, X. Duan et al., Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.2, pp.189-195, 2011.
DOI : 10.1136/jnnp.2010.227942

J. C. Mcdonald, J. R. Oksenberg, P. Bacchetti, and E. Waubant, Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis, Ann. Neurol, vol.67, pp.618-624, 2010.

S. Simpson, . Jr, B. Taylor, L. Blizzard, A. L. Ponsonby et al., Mei, I. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis, Ann. Neurol, vol.68, pp.193-203, 2010.

P. Goldberg, M. C. Fleming, and E. H. Picard, Multiple sclerosis: Decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D, Medical Hypotheses, vol.21, issue.2, pp.193-200, 1986.
DOI : 10.1016/0306-9877(86)90010-1

I. Nordvik, K. M. Myhr, H. Nyland, and K. S. Bjerve, Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients, Acta Neurologica Scandinavica, vol.102, issue.3, pp.143-149, 2000.
DOI : 10.1034/j.1600-0404.2000.102003143.x

B. D. Mahon, S. A. Gordon, J. Cruz, F. Cosman, and M. T. Cantorna, Cytokine profile in patients with multiple sclerosis following vitamin D supplementation, Journal of Neuroimmunology, vol.134, issue.1-2, pp.128-132, 2003.
DOI : 10.1016/S0165-5728(02)00396-X

S. M. Kimball, M. R. Ursell, P. O-'connor, and R. Vieth, Safety of vitamin D3 in adults with multiple sclerosis, The American Journal of Clinical Nutrition, vol.85, issue.3, pp.645-651, 2007.
DOI : 10.1093/ajcn/85.1.6

J. M. Burton, S. Kimball, R. Vieth, A. Bar-or, H. M. Dosch et al., A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis, Neurology, vol.74, issue.23, pp.1852-1859, 2010.
DOI : 10.1212/WNL.0b013e3181e1cec2

S. Kimball, R. Vieth, H. M. Dosch, A. Bar-or, R. Cheung et al., Cholecalciferol Plus Calcium Suppresses Abnormal PBMC Reactivity in Patients with Multiple Sclerosis, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.9, pp.2826-2834, 2011.
DOI : 10.1210/jc.2011-0325

J. Smolders, E. Peelen, M. Thewissen, J. W. Cohen-tervaert, P. Menheere et al., Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple Sclerosis, PLoS ONE, vol.33, issue.12, p.15235, 2010.
DOI : 10.1371/journal.pone.0015235.s001

G. Mosayebi, A. Ghazavi, K. Ghasami, Y. Jand, and P. Kokhaei, Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients, Immunological Investigations, vol.74, issue.6, pp.627-639, 2011.
DOI : 10.1016/j.smim.2009.08.003

M. T. Kampman, L. H. Steffensen, S. I. Mellgren, and L. Jørgensen, supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial, Multiple Sclerosis Journal, vol.68, issue.8, pp.1144-1151, 2012.
DOI : 10.1016/j.jneuroim.2011.03.003

P. Tienari, S. Atula, T. Sarasoja, and L. Herrala, A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon ?-1b in patients with multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, vol.83, pp.565-571, 2012.

J. Smolders, R. Hupperts, F. Barkhof, L. M. Grimaldi, T. Holmoy et al., Efficacy of vitamin D3 as add-on therapy in patients with relapsing???remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial, Journal of the Neurological Sciences, vol.311, issue.1-2, pp.311-355, 2011.
DOI : 10.1016/j.jns.2011.04.013

J. H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B. G. Weinshenker, Multiple Sclerosis, New England Journal of Medicine, vol.343, issue.13, pp.938-952, 2000.
DOI : 10.1056/NEJM200009283431307

E. Mellanby, Nutritional Influences on the Nervous System-Experimental Work on Animals In Nutrition and Disease. The Interaction of Clinical and Experimental Work on Animals, pp.98-118, 1934.

M. Pfeifer, B. Begerow, and H. W. Minne, Vitamin D and Muscle Function, Osteoporosis International, vol.13, issue.3, pp.187-194, 2002.
DOI : 10.1007/s001980200012

S. J. Birge and J. G. Haddad, 25-hydroxycholecalciferol stimulation of muscle metabolism., Journal of Clinical Investigation, vol.56, issue.5, pp.1100-1107, 1975.
DOI : 10.1172/JCI108184

S. J. Wassner, J. B. Li, A. Sperduto, and M. E. Norman, Vitamin D Deficiency, hypocalcemia, and increased skeletal muscle degradation in rats., Journal of Clinical Investigation, vol.72, issue.1, pp.102-112, 1983.
DOI : 10.1172/JCI110947

J. F. Chabas, O. Alluin, G. Rao, S. Garcia, M. N. Lavaut et al., Potentiates Axon Regeneration, Journal of Neurotrauma, vol.25, issue.10, pp.1247-1256, 2008.
DOI : 10.1089/neu.2008.0593
URL : https://hal.archives-ouvertes.fr/hal-00320785

O. H. Sørensen, B. Lund, B. Saltin, B. Lund, R. B. Andersen et al., Myopathy in Bone Loss of Ageing: Improvement by Treatment with 1??-hydroxycholecalciferol and Calcium, Clinical Science, vol.56, issue.2, pp.157-161, 1979.
DOI : 10.1042/cs0560157

Y. Sato, J. Iwamoto, T. Kanoko, and K. Satoh, Low-Dose Vitamin D Prevents Muscular Atrophy and Reduces Falls and Hip Fractures in Women after Stroke: A Randomized Controlled Trial, Cerebrovascular Diseases, vol.20, issue.3, pp.187-192, 2005.
DOI : 10.1016/0304-4165(76)90339-1

L. D. Moreira-pfrimer, M. A. Pedrosa, L. Teixeira, and M. Lazaretti-castro, Treatment of Vitamin D Deficiency Increases Lower Limb Muscle Strength in Institutionalized Older People Independently of Regular Physical Activity: A Randomized Double-Blind Controlled Trial, Annals of Nutrition and Metabolism, vol.54, issue.4, pp.291-300, 2009.
DOI : 10.1159/000235874

B. Dawson-hughes, R. P. Heaney, M. F. Holick, P. Lips, and P. J. Meunier, Estimates of optimal vitamin D status, Osteoporosis International, vol.90, issue.7, pp.713-716, 2005.
DOI : 10.7326/0003-4819-124-4-199602150-00003

J. L. Geller, J. S. Adams, D. Vitamin, and . Therapy, Vitamin D therapy, Current Osteoporosis Reports, vol.85, issue.1, pp.5-11, 2008.
DOI : 10.7326/0003-4819-127-3-199708010-00004

P. Lips, Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications, Endocrine Reviews, vol.22, issue.4, pp.477-501, 2001.
DOI : 10.1210/edrv.22.4.0437

J. Nieves, F. Cosman, J. Herbert, V. Shen, and R. Lindsay, High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis, Neurology, vol.44, issue.9, pp.1687-1692, 1994.
DOI : 10.1212/WNL.44.9.1687

F. Cosman, J. Nieves, L. Komar, G. Ferrer, J. Herbert et al., Fracture history and bone loss in patients with MS, Neurology, vol.51, issue.4, pp.1161-1165, 1998.
DOI : 10.1212/WNL.51.4.1161

B. Weinstock-guttman, E. Gallagher, M. Baier, L. Green, J. Feichter et al., Risk of bone loss in men with multiple sclerosis, Multiple Sclerosis Journal, vol.83, issue.2, pp.170-175, 2004.
DOI : 10.1210/jcem.83.3.4621

L. H. Steffensen, S. I. Mellgren, and M. T. Kampman, Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis, Journal of Neurology, vol.12, issue.3, pp.410-418, 2010.
DOI : 10.1001/archneur.1996.00550080071014

L. H. Steffensen, L. Jørgensen, B. Straume, S. I. Mellgren, and M. T. Kampman, Can vitamin D3 supplementation prevent bone loss in persons with MS? A placebo-controlled trial, Journal of Neurology, vol.10, issue.9, pp.1624-1631, 2011.
DOI : 10.1191/1352458504ms993oa

R. A. Marrie, G. Cutter, T. Tyry, and T. Vollmer, A cross-sectional study of bone health in multiple sclerosis, Neurology, vol.73, issue.17, pp.1394-1398, 2009.
DOI : 10.1212/WNL.0b013e3181beece8

S. M. Moen, E. G. Celius, L. Sandvik, L. Nordsletten, E. F. Eriksen et al., Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome, Neurology, vol.77, issue.2, pp.151-157, 2011.
DOI : 10.1212/WNL.0b013e3182242d34

M. T. Kampman, E. F. Eriksen, and T. Holmøy, Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications?, Acta Neurologica Scandinavica, vol.30, issue.Suppl. 191, pp.44-49
DOI : 10.1159/000122330

S. M. Kimball, J. M. Burton, P. G. O-'connor, and R. Vieth, Urinary calcium response to high dose vitamin D3 with calcium supplementation in patients with multiple sclerosis, Clinical Biochemistry, vol.44, issue.10-11, pp.930-932, 2011.
DOI : 10.1016/j.clinbiochem.2011.04.017

J. Kurtzke, Geography in multiple sclerosis, Journal of Neurology, vol.86, issue.19, pp.1-26, 1977.
DOI : 10.1212/WNL.21.12.1186

E. L. Hoogervorst, L. M. Van-winsen, M. J. Eikelenboom, N. F. Kalkers, B. M. Uitdehaag et al., Comparisons of patient self-report, neurologic examination, and functional impairment in MS, Neurology, vol.56, issue.7, pp.934-937, 2001.
DOI : 10.1212/WNL.56.7.934

N. F. Kalkers, V. De-groot, R. H. Lazeron, J. Killestein, H. J. Adèr et al., MS Functional Composite: Relation to disease phenotype and disability strata, Neurology, vol.54, issue.6, pp.1233-1239, 2000.
DOI : 10.1212/WNL.54.6.1233

S. Kimball and R. Vieth, Self-prescribed high-dose vitamin D<SUB>3</SUB>: effects on biochemical parameters in two men, Annals of Clinical Biochemistry, vol.45, issue.1, pp.106-110, 2008.
DOI : 10.1258/acb.2007.007074

R. Vieth, The Pharmacology of Vitamin D, pp.1041-1076, 2011.
DOI : 10.1016/B978-0-12-381978-9.10057-5

M. F. Holick, Vitamin D Deficiency, New England Journal of Medicine, vol.357, issue.3, pp.266-281, 2007.
DOI : 10.1056/NEJMra070553

J. D. Roder and E. L. Stair, An overview of cholecalciferol toxicosis, Vet. Hum. Toxicol, vol.41, pp.344-343, 1999.

M. J. Barger-lux, R. P. Heaney, S. Dowell, T. C. Chen, and M. F. Holick, Vitamin D and its Major Metabolites: Serum Levels after Graded Oral Dosing in Healthy Men, Osteoporosis International, vol.8, issue.3, pp.222-230, 1998.
DOI : 10.1007/s001980050058

K. M. Sanders, A. L. Stuart, E. J. Williamson, J. A. Simpson, M. A. Kotowicz et al., Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women, JAMA, vol.303, issue.18, pp.1815-1822, 2010.
DOI : 10.1001/jama.2010.594

J. Reusch, H. Ackermann, and K. Badenhoop, Cyclic Changes of Vitamin D and PTH are Primarily Regulated by Solar Radiation: 5-Year Analysis of a German (50?? N) Population, Hormone and Metabolic Research, vol.41, issue.05, pp.402-407, 2009.
DOI : 10.1055/s-0028-1128131

G. Karaguzel and M. F. Holick, Diagnosis and treatment of osteopenia, Reviews in Endocrine and Metabolic Disorders, vol.361, issue.4, pp.237-251, 2010.
DOI : 10.1056/NEJMoa0809493

M. H. Lafage-proust, T. Dresselaers, J. Q. Feng, and L. F. Bonewald, Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization, J. Clin. Invest, vol.122, pp.1803-1815, 2012.

V. Mocanu, P. A. Stitt, A. R. Costan, O. Voroniuc, E. Zbranca et al., Long-term effects of giving nursing home residents bread fortified with 125 ??g (5000 IU) vitamin D3 per daily serving, The American Journal of Clinical Nutrition, vol.85, issue.suppl 2, pp.1132-1137, 2009.
DOI : 10.1359/jbmr.07s221

A. A. Ginde, P. Wolfe, C. A. Camargo, . Jr, and R. S. Schwartz, Defining Vitamin D Status by Secondary Hyperparathyroidism in the U.S. Population, J. Endocrinol. Invest, vol.35, pp.42-48, 2012.

G. A. Ledger, M. F. Burritt, P. C. Kao, W. M. O-'fallon, B. L. Riggs et al., Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3, J. Clin. Endocrinol. Metab, vol.79, pp.211-216, 1994.

W. R. Mckane, S. Khosla, K. S. Egan, S. P. Robins, M. F. Burritt et al., Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption, J. Clin. Endocrinol. Metab, vol.81, pp.1699-1703, 1996.

M. U. Kärkkäinen, C. J. Lamberg-allardt, S. Ahonen, and M. Valimaki, Does it make a difference how and when you take your calcium? The acute effects of calcium on calcium and bone metabolism, The American Journal of Clinical Nutrition, vol.83, issue.3, pp.335-342, 2001.
DOI : 10.1172/JCI116273

H. Aydin, O. Deyneli, D. Yavuz, H. Gözü, N. Mutlu et al., Short-Term Oral Magnesium Supplementation Suppresses Bone Turnover in Postmenopausal Osteoporotic Women, Biological Trace Element Research, vol.110, issue.2, pp.136-143, 2010.
DOI : 10.1358/dot.1999.35.3.533847

G. R. Corazza, A. Di-sario, L. Cecchetti, C. Tarozzi, G. Corrao et al., Bone mass and metabolism in patients with celiac disease, Gastroenterology, vol.109, issue.1, pp.122-128, 1995.
DOI : 10.1016/0016-5085(95)90276-7

P. L. Selby, M. Davies, J. E. Adams, and E. B. Mawer, Bone Loss in Celiac Disease Is Related to Secondary Hyperparathyroidism, Journal of Bone and Mineral Research, vol.60, issue.4, pp.652-657, 1999.
DOI : 10.1136/bmj.312.7041.1254

R. K. Rude and M. Olerich, Magnesium deficiency: Possible role in osteoporosis associated with gluten-sensitive enteropathy, Osteoporosis International, vol.6, issue.6, pp.453-461, 1996.
DOI : 10.1007/BF01629578

G. S. Ramsaransing, S. A. Mellema, and J. De-keyser, Dietary patterns in clinical subtypes of multiple sclerosis: an exploratory study, Nutrition Journal, vol.70, issue.Suppl, p.36, 2009.
DOI : 10.1034/j.1600-0404.2000.102003143.x

R. Sinert, S. Zehtabchi, S. Desai, P. Peacock, B. T. Altura et al., Serum ionized magnesium and calcium levels in adult patients with seizures, Scandinavian Journal of Clinical and Laboratory Investigation, vol.89, issue.217, pp.317-326, 2007.
DOI : 10.1042/cs0890633

L. A. Plum and H. Deluca, Vitamin D, disease and therapeutic opportunities, Nature Reviews Drug Discovery, vol.14, issue.4, pp.941-955, 2010.
DOI : 10.1016/1078-1439(95)00061-5

J. Smolders and J. Damoiseaux, Vitamin D as a T-cell modulator in multiple sclerosis. Vitam Horm, pp.401-428, 2011.

D. A. Fernandes-de-abreu and D. Eyles, Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases, Psychoneuroendocrinology, vol.34, pp.265-277, 2009.
DOI : 10.1016/j.psyneuen.2009.05.023
URL : https://hal.archives-ouvertes.fr/hal-00417412

D. A. Fernandes-de-abreu, V. Landel, and F. Féron, Seasonal, gestational and postnatal influences on multiple sclerosis: The beneficial role of a vitamin D supplementation during early life, Journal of the Neurological Sciences, vol.311, issue.1-2, pp.311-64, 2011.
DOI : 10.1016/j.jns.2011.08.044

J. Bianco, Y. Gueye, T. Marqueste, O. Alluin, J. J. Risso et al., Vitamin D3 improves respiratory adjustment to fatigue and H-reflex responses in paraplegic adult rats, Neuroscience, vol.188, pp.182-192, 2011.
DOI : 10.1016/j.neuroscience.2011.04.066

S. Wergeland, Ø. Torkildsen, K. M. Myhr, L. Aksnes, S. J. Mørk et al., Dietary Vitamin D3 Supplements Reduce Demyelination in the Cuprizone Model, PLoS ONE, vol.129, issue.10, p.26262, 2011.
DOI : 10.1371/journal.pone.0026262.s002

J. J. Cannell, B. W. Hollis, M. B. Sorenson, T. N. Taft, and J. J. Anderson, Athletic Performance and Vitamin D, Medicine & Science in Sports & Exercise, vol.41, issue.5, pp.1102-1110, 2009.
DOI : 10.1249/MSS.0b013e3181930c2b

F. M. Alexander, The Use of the Self. Its Conscious Direction in Relation to Diagnosis, Functioning, and the Control of Reaction, 1946.

B. Carrière, The Swiss Ball: Theory, Basic Exercises and Clinical Application, 1998.

F. M. Gloth, J. M. Lindsay, L. B. Zelesnick, W. B. Greenough, and ?. , Can Vitamin D Deficiency Produce an Unusual Pain Syndrome?, Archives of Internal Medicine, vol.151, issue.8, pp.1662-1664, 1991.
DOI : 10.1001/archinte.1991.00400080144029

H. Glerup and E. Eriksen, Acroparaesthesia--a typical finding in vitamin D deficiency., Rheumatology, vol.38, issue.5, p.482, 1999.
DOI : 10.1093/rheumatology/38.5.482

D. Torrenté-de-la-jara, G. Pécoud, A. Favrat, and B. , Female asylum seekers with musculoskeletal pain: the importance of diagnosis and treatment of hypovitaminosis D, BMC Family Practice, vol.317, issue.1, 2004.
DOI : 10.1136/bmj.317.7171.1466

S. E. Tague and P. G. Smith, Vitamin D receptor and enzyme expression in dorsal root ganglia of adult female rats: Modulation by ovarian hormones, Journal of Chemical Neuroanatomy, vol.41, issue.1, pp.1-12, 2011.
DOI : 10.1016/j.jchemneu.2010.10.001

S. E. Tague, G. L. Clarke, M. K. Winter, K. E. Mccarson, D. E. Wright et al., Vitamin D Deficiency Promotes Skeletal Muscle Hypersensitivity and Sensory Hyperinnervation, Journal of Neuroscience, vol.31, issue.39, pp.31-13728, 2011.
DOI : 10.1523/JNEUROSCI.3637-11.2011
URL : http://www.jneurosci.org/content/jneuro/31/39/13728.full.pdf

. Patientslikeme, Available online: http://www, patientslikeme.com, 2012.

S. Katz and S. Weinerman, Osteoporosis and gastrointestinal disease, Gastroenterol. Hepatol, vol.6, pp.506-517, 2010.

K. Kaukinen, C. P. Kelly, and J. N. Leonard, The Oslo definitions for coeliac disease and related terms, Gut, 2012.

M. Zaidi and J. D. Maxwell, Calcium absorption and bone mineral density in celiacs after long term treatment with gluten-free diet and adequate calcium intake, Osteoporos. Int, vol.16, pp.56-63, 2005.

D. M. Wingerchuk, Smoking: effects on multiple sclerosis susceptibility and disease progression, Therapeutic Advances in Neurological Disorders, vol.24, issue.1, pp.13-22, 2012.
DOI : 10.1002/msj.20240

D. P. Robinson and S. L. Klein, Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis, Hormones and Behavior, vol.62, issue.3, 2012.
DOI : 10.1016/j.yhbeh.2012.02.023
URL : http://europepmc.org/articles/pmc3376705?pdf=render

M. B. Rietberg, D. Brooks, B. M. Uitdehaag, and G. Kwakkel, Exercise therapy for multiple sclerosis, Cochrane Database Syst. Rev, vol.25, p.3980, 2005.

J. B. Segal and N. R. Powe, Prevalence of immune thrombocytopenia: analyses of administrative data, Journal of Thrombosis and Haemostasis, vol.22, issue.11, pp.2377-2383, 2006.
DOI : 10.7326/0003-4819-138-3-200302040-00028

L. L. Horstman, W. Jy, Y. S. Ahn, R. Zivadinov, A. H. Maghzi et al., Role of platelets in neuroinflammation: a wide-angle perspective, Journal of Neuroinflammation, vol.7, issue.1, 2010.
DOI : 10.1186/1742-2094-7-10

G. K. Schwalfenberg, Solar Radiation and Vitamin D: Mitigating Environmental Factors in Autoimmune Disease, Journal of Environmental and Public Health, vol.100, issue.7, article cd007470, p.619381, 2012.
DOI : 10.1016/j.pbiomolbio.2009.02.003

L. Rodrigo, C. Hernández-lahoz, D. Fuentes, and N. Alvarez, López-Vázquez, A.; González, S. Prevalence of celiac disease in multiple sclerosis, BioMed Central Neurol, issue.11, p.31, 2011.

J. Gutierrez-achury, R. Coutinho-de-almeida, and C. Wijmenga, Shared genetics in coeliac disease and other immune-mediated diseases, Journal of Internal Medicine, vol.5, issue.Suppl 4, pp.591-603, 2011.
DOI : 10.1371/journal.pgen.1000534

O. Olén, S. M. Montgomery, G. Elinder, A. Ekbom, and J. Ludvigsson, Increased risk of immune thrombocytopenic purpura among inpatients with coeliac disease, Scandinavian Journal of Gastroenterology, vol.95, issue.1, pp.416-422, 2008.
DOI : 10.1136/gut.2003.032094

M. Hadjivassiliou, D. S. Sanders, R. A. Grünewald, N. Woodroofe, S. Boscolo et al., Gluten sensitivity: from gut to brain, The Lancet Neurology, vol.9, issue.3, pp.318-330, 2010.
DOI : 10.1016/S1474-4422(09)70290-X

C. Hernández-lahoz and L. Rodrigo, Gluten sensitivity and the CNS: diagnosis and treatment, The Lancet Neurology, vol.9, issue.7, p.653, 2010.
DOI : 10.1016/S1474-4422(10)70149-6

R. Phan-ba, N. Lambinet, E. Louis, P. Delvenne, L. Tshibanda et al., Natalizumab to kill two birds with one stone, Inflammatory Bowel Diseases, vol.369, issue.6, pp.62-63, 2011.
DOI : 10.1016/S0140-6736(07)60751-X